082850 — Wooree Bio Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩184bn
- KR₩178bn
- KR₩1tn
- 93
- 93
- 52
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,672,648 | 1,623,383 | 1,543,312 | 1,355,056 | 1,263,944 |
Cost of Revenue | |||||
Gross Profit | 89,315 | 100,796 | 116,480 | 114,573 | 116,348 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,647,457 | 1,584,385 | 1,500,480 | 1,320,673 | 1,237,948 |
Operating Profit | 25,192 | 38,997 | 42,832 | 34,383 | 25,996 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10,397 | 22,224 | 45,281 | 32,026 | 21,729 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6,096 | 16,983 | 44,041 | 25,126 | 18,946 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4,532 | 16,841 | 33,156 | 21,822 | 15,581 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4,532 | 17,030 | 33,606 | 21,822 | 15,581 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 124 | 529 | 706 | 467 | 332 |
Dividends per Share |